Finding Effective Treatments for COVID-19: Scientific Integrity and Public Confidence in a Time of Crisis

This Viewpoint discusses the risks to patients and public health posed by the FDA's politically pressured Emergency Use Authorization (EUA) of chloroquine and hydroxychloroquine for COVID-19 treatment, and proposes principles to follow to ensure new therapies are studied properly and quickly to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA : the journal of the American Medical Association 2020-05, Vol.323 (19), p.1899-1900
Hauptverfasser:	Goodman, Jesse L, Borio, Luciana
Format:	Artikel
Sprache:	eng
Schlagworte:	Betacoronavirus Chloroquine Compassionate Use Trials Coronavirus Infections - epidemiology Coronaviruses COVID-19 General & Internal Medicine Humans Hydroxychloroquine Life Sciences & Biomedicine Medicine, General & Internal Off-Label Use Pandemics Pneumonia, Viral - epidemiology Public concern Public health Randomized Controlled Trials as Topic SARS-CoV-2 Science & Technology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This Viewpoint discusses the risks to patients and public health posed by the FDA's politically pressured Emergency Use Authorization (EUA) of chloroquine and hydroxychloroquine for COVID-19 treatment, and proposes principles to follow to ensure new therapies are studied properly and quickly to maximize benefits and minimize risks to patients.
ISSN:	0098-7484 1538-3598
DOI:	10.1001/jama.2020.6434